These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38867679)

  • 21. From SARS to H7N9: the mechanism of responding to emerging communicable diseases has made great progress in China.
    Yao L; Chen E; Chen Z; Gong Z
    Biosci Trends; 2013 Dec; 7(6):290-3. PubMed ID: 24390368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive large-scale nucleic acid-testing strategies support China's sustained containment of COVID-19.
    Li Z; Liu F; Cui J; Peng Z; Chang Z; Lai S; Chen Q; Wang L; Gao GF; Feng Z
    Nat Med; 2021 May; 27(5):740-742. PubMed ID: 33859409
    [No Abstract]   [Full Text] [Related]  

  • 23. China in action: national strategies to combat against emerging infectious diseases.
    Han M; Gu J; Gao GF; Liu WJ
    Sci China Life Sci; 2017 Dec; 60(12):1383-1385. PubMed ID: 28887624
    [No Abstract]   [Full Text] [Related]  

  • 24. Travel restrictions in the rising COVID-19 pandemic.
    Xue W; Lam C; Yeung HH; Wong CS; Chan VLY; Wong YS
    Hong Kong Med J; 2020 Jun; 26(3):255-257. PubMed ID: 32487773
    [No Abstract]   [Full Text] [Related]  

  • 25. Satellite reveals a steep decline in China's CO
    Li H; Zheng B; Ciais P; Boersma KF; Riess TCVW; Martin RV; Broquet G; van der A R; Li H; Hong C; Lei Y; Kong Y; Zhang Q; He K
    Sci Adv; 2023 Jul; 9(29):eadg7429. PubMed ID: 37478188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [About the new coronavirus: Microbiotourism].
    Albert-Hernández M
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 38(10):510. PubMed ID: 32513508
    [No Abstract]   [Full Text] [Related]  

  • 27. Effective actions against the second wave of COVID-19: the front-line experience from China.
    Xu JW; Liu JQ; Ke L; Wang JN; Sun CY; Gao L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11995-11997. PubMed ID: 33336783
    [No Abstract]   [Full Text] [Related]  

  • 28. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. China's experience on mental health in response to the COVID-19 pandemic.
    Yan B; Nie G; Huang Y
    Asian J Psychiatr; 2020 Oct; 53():102205. PubMed ID: 32563108
    [No Abstract]   [Full Text] [Related]  

  • 30. Facing challenges with the novel coronavirus SARS-CoV-2 outbreak.
    van der Werf S; Peltekian C
    Virologie (Montrouge); 2020 Apr; 24(S1):e12-15. PubMed ID: 32186279
    [No Abstract]   [Full Text] [Related]  

  • 31. Vaccines as remedy for antimicrobial resistance and emerging infections.
    Troisi M; Andreano E; Sala C; Kabanova A; Rappuoli R
    Curr Opin Immunol; 2020 Aug; 65():102-106. PubMed ID: 33289646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 control and preventive measures: a medico-legal analysis.
    Li VWT; Wan TTW
    Hong Kong Med J; 2021 Jun; 27(1):224-225. PubMed ID: 34127560
    [No Abstract]   [Full Text] [Related]  

  • 33. Public health professionals' perceptions of the capacity of China's CDCs to address emerging and re-emerging infectious diseases.
    Tong MX; Hansen A; Hanson-Easey S; Xiang J; Cameron S; Liu Q; Liu X; Sun Y; Weinstein P; Han GS; Mahmood A; Bi P
    J Public Health (Oxf); 2021 Apr; 43(1):209-216. PubMed ID: 31251367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Coronavirus Pandemic 1 Year On-What Went Wrong?
    Gostin LO
    JAMA; 2021 Mar; 325(12):1132-1133. PubMed ID: 33755061
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of the COVID-19 in Iraq - Implications for travellers.
    Al-Malkey MK; Al-Sammak MA
    Travel Med Infect Dis; 2020; 38():101739. PubMed ID: 32405265
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous focus on COVID-19 epidemic: Changes in China's clinical guidance.
    Wang QC; Wang ZY
    Int J Clin Pract; 2021 Mar; 75(3):e13869. PubMed ID: 33264484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cambodia ends controversial COVID-19 restrictions.
    Tatum M
    Lancet; 2021 May; 397(10289):2035. PubMed ID: 34062135
    [No Abstract]   [Full Text] [Related]  

  • 38. A framework to guide research and practice response to emerging infectious diseases: Genomic-to-global considerations.
    Prescott S; Schminkey D; Abukhalaf D; DeGuzman P; Dreisbach C
    Public Health Nurs; 2023 Jan; 40(1):144-152. PubMed ID: 36128924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statewide Stay-at-Home Directives on the Spread of COVID-19 in Metropolitan and Nonmetropolitan Counties in the United States.
    Lin G; Zhang T; Zhang Y; Wang Q
    J Rural Health; 2021 Jan; 37(1):222-223. PubMed ID: 32391620
    [No Abstract]   [Full Text] [Related]  

  • 40. Multi-dimensional effects of the COVID-19 pandemic considering the WHO's ecological approach.
    Tabari P; Amini M; Khoshnood K; Arya N
    Glob Public Health; 2021 Jan; 16(1):136-148. PubMed ID: 33125297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.